The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-line osemitamab (TST001) plus nivolumab and capox for advanced g/GEJ cancer (TranStar102): Results of cohort G from a phase I/IIa study.
 
Xiaotian Zhang
No Relationships to Disclose
 
Zengqing Guo
No Relationships to Disclose
 
Jingdong Zhang
No Relationships to Disclose
 
Weijian Guo
No Relationships to Disclose
 
Meili Sun
No Relationships to Disclose
 
Nong Xu
Research Funding - MSD (Inst)
 
Charlie Qi
Employment - Transcenta
Stock and Other Ownership Interests - Transcenta
 
Xuelian Zhu
Employment - Transcenta
Stock and Other Ownership Interests - Transcenta
 
Lijuan Zhang
Employment - Transcenta
Stock and Other Ownership Interests - Transcenta
 
Xueming Qian
Employment - Transcenta
Leadership - Transcenta
Stock and Other Ownership Interests - Transcenta
 
Caroline Germa
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Consulting or Advisory Role - C4 Therapeutics; Immunitas
 
Lin Shen
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD; SERVIER; Transcenta Holding Limited
Research Funding - BeiGene (Inst)